Konklusionen er, at dataene vedrørende virkningen anses for at være for svage til at understøtte en pædiatrisk indikation af øsofagitis hos børn og unge.
In conclusion, the efficacy data are considered too weak to support a paediatric indication of oesophagitis in children and adolescents.